110 related articles for article (PubMed ID: 17201121)
1. COX-independent antineoplastic effects of sulindac in oral cancer are mediated by survivin down-regulation.
Scheper MA; Sauk JJ; Nikitakis NG
Anticancer Res; 2006; 26(6B):4103-13. PubMed ID: 17201121
[TBL] [Abstract][Full Text] [Related]
2. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
Scheper MA; Nikitakis NG; Sauk JJ
Int J Oral Maxillofac Surg; 2007 Jul; 36(7):632-9. PubMed ID: 17566705
[TBL] [Abstract][Full Text] [Related]
3. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.
Jin HO; Yoon SI; Seo SK; Lee HC; Woo SH; Yoo DH; Lee SJ; Choe TB; An S; Kwon TJ; Kim JI; Park MJ; Hong SI; Park IC; Rhee CH
Biochem Pharmacol; 2006 Nov; 72(10):1228-36. PubMed ID: 16950207
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis and cell cycle arrest by NS398 in oral squamous cell carcinoma cells via downregulation of E2 promoter-binding factor-1.
Du Y; Zhang S; Wang Z; Zhou W; Luan M; Yang X; Chen N
Oncol Rep; 2008 Sep; 20(3):605-11. PubMed ID: 18695912
[TBL] [Abstract][Full Text] [Related]
5. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
Liu B; Shi ZL; Feng J; Tao HM
Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
[TBL] [Abstract][Full Text] [Related]
7. Suppression of survivin expression by short hairpin RNA induces apoptosis in human laryngeal carcinoma cells.
Chen XM; Luan XY; Lei DP; Ma XJ; Liu XX; Liu J; Pan XL
ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):168-75. PubMed ID: 18391576
[TBL] [Abstract][Full Text] [Related]
8. The nonsteroidal anti-inflammatory drug sulindac causes down-regulation of signal transducer and activator of transcription 3 in human oral squamous cell carcinoma cells.
Nikitakis NG; Hamburger AW; Sauk JJ
Cancer Res; 2002 Feb; 62(4):1004-7. PubMed ID: 11861373
[TBL] [Abstract][Full Text] [Related]
9. The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac.
Nikitakis NG; Scheper MA; Papanikolaou VS; Sauk JJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jun; 107(6):826-36. PubMed ID: 19272804
[TBL] [Abstract][Full Text] [Related]
10. Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer.
Hou JQ; He J; Wang XL; Wen DG; Chen ZX
Chin Med J (Engl); 2006 Oct; 119(20):1734-9. PubMed ID: 17097022
[TBL] [Abstract][Full Text] [Related]
11. Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.
Lin J; Hsiao PW; Chiu TH; Chao JI
Biochem Pharmacol; 2005 Sep; 70(5):658-67. PubMed ID: 16004971
[TBL] [Abstract][Full Text] [Related]
12. siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth.
Ning S; Fuessel S; Kotzsch M; Kraemer K; Kappler M; Schmidt U; Taubert H; Wirth MP; Meye A
Int J Oncol; 2004 Oct; 25(4):1065-71. PubMed ID: 15375557
[TBL] [Abstract][Full Text] [Related]
13. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma.
Lo Muzio L; Staibano S; Pannone G; Mignogna MD; Mariggiò A; Salvatore G; Chieffi P; Tramontano D; De Rosa G; Altieri DC
Exp Mol Pathol; 2001 Jun; 70(3):249-54. PubMed ID: 11418003
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide induced the apoptosis of laryngeal cancer via down-regulation of survivin mRNA.
Cheng B; Yang X; Han Z; An L; Liu S
Auris Nasus Larynx; 2008 Mar; 35(1):95-101. PubMed ID: 17869043
[TBL] [Abstract][Full Text] [Related]
15. Sulindac induces apoptosis and inhibits tumor growth in vivo in head and neck squamous cell carcinoma.
Scheper MA; Nikitakis NG; Chaisuparat R; Montaner S; Sauk JJ
Neoplasia; 2007 Mar; 9(3):192-9. PubMed ID: 17401459
[TBL] [Abstract][Full Text] [Related]
16. PPARgamma-mediated antineoplastic effect of NSAID sulindac on human oral squamous carcinoma cells.
Nikitakis NG; Hebert C; Lopes MA; Reynolds MA; Sauk JJ
Int J Cancer; 2002 Apr; 98(6):817-23. PubMed ID: 11948457
[TBL] [Abstract][Full Text] [Related]
17. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N
Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen inhibits proliferation and induces apoptosis in human hepatocellular carcinoma cell line HepG2 via down-regulation of survivin expression.
Guo R; Huang Z; Shu Y; Jin S; Ge H
Biomed Pharmacother; 2009 Jun; 63(5):375-9. PubMed ID: 18993026
[TBL] [Abstract][Full Text] [Related]
19. The chemopreventive agent sulindac attenuates expression of the antiapoptotic protein survivin in colorectal carcinoma cells.
Zhang T; Fields JZ; Ehrlich SM; Boman BM
J Pharmacol Exp Ther; 2004 Feb; 308(2):434-7. PubMed ID: 14610217
[TBL] [Abstract][Full Text] [Related]
20. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
Gu L; Chiang KY; Zhu N; Findley HW; Zhou M
Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]